What Influence Re-participation in the Danish Colorectal Screening Program.

Re-participation for Screening-colonoscopy - Experience of colonoscpy_1

This prospective observational study investigates how participants experience screening colonoscopy within the Danish colorectal cancer screening program and how these experiences relate to clinical findings, procedural factors, and future participation in screening.

The study aims to evaluate patient-reported experiences such as pain, discomfort, preparation burden, emotional responses, and perceptions of healthcare staff, as well as staff-assessed pain during the procedure. These experiences will be examined in relation to colonoscopy findings, including polyp detection, histology, risk stratification, and colorectal cancer detection. In addition, procedure-specific variables such as insertion time, bowel preparation quality, completeness of colonoscopy, medication use, and adenoma detection rate will be analyzed in relation to patient experience.

A key focus is whether the experience of screening colonoscopy influences subsequent participation in the colorectal cancer screening program, particularly among individuals classified as low risk and re-invited for screening after two years. Registry-based follow-up will be used to assess re-participation.

Data are collected prospectively from two sources: (1) real-time procedure data entered by healthcare staff during colonoscopy and (2) patient-reported outcomes collected via a questionnaire completed shortly after the procedure. Additional outcome data are obtained from electronic medical records and national health and screening registries.

The study has no single predefined hypothesis. Instead, it serves as a data-generating platform designed to address both predefined and future research questions related to screening colonoscopy experiences, quality indicators, and screening adherence.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

8000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Anitta Øhlenschlæger, Research secretary
  • Phone Number: +45 21 33 86 07
  • Email: SVS-Forskning@rsyd.dk

Study Locations

      • Aabenraa, Denmark
        • Recruiting
        • Sygehus Sønderjylland, University hospital of Southern Denmark
      • Esbjerg, Denmark, 6700
        • Recruiting
        • Esbjerg Hospital, University Hospital of Southern Denmark
        • Contact:
      • Grindsted, Denmark, 7200
        • Recruiting
        • Grindsted Sygehus
      • Gødstrup, Denmark
        • Recruiting
        • Regionshospitalet Gødstrup
      • Holbæk, Denmark
        • Recruiting
        • Holbæk Sygehus
      • Køge, Denmark
        • Recruiting
        • Sjællands Universitetshospital Køge
      • Nykøbing Falster, Denmark
        • Recruiting
        • Sjællands Universitetshospital, Nykøbing
      • Slagelse, Denmark
        • Recruiting
        • Slagelse Sygehus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Adults undergoing a screening colonoscpy

Description

Inclusion Criteria:

  • Adults undergoing screening-derived colonoscopy as part of the Danish colorectal cancer screening program
  • Written informed consent

Exclusion Criteria:

  • Inability to understand or communicate in Danish
  • Lack of decision-making capacity, including cognitive impairment due to dementia or brain injury
  • Declines or withdraws informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain experienced during colonoscopy, reported by the patient
Time Frame: apr. 15min after colonoscopy
11-point numerical rating scale ranging from 0 (least pain) to 10(most pain)
apr. 15min after colonoscopy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Re-participation in screening
Time Frame: 2 years following colonoscopy
2-year Re-participation rate for those calssified as low risk after index colonoscopy
2 years following colonoscopy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 23, 2024

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

December 29, 2025

First Submitted That Met QC Criteria

January 19, 2026

First Posted (Actual)

January 20, 2026

Study Record Updates

Last Update Posted (Actual)

January 20, 2026

Last Update Submitted That Met QC Criteria

January 19, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Subscribe